ArticleClinical drug investigation2019

Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese Volunteers.

Nan Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.